Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other financing activities (2019 - 2025)

Haemonetics has reported Other financing activities over the past 15 years, most recently at -$89000.0 for Q4 2025.

  • For Q4 2025, Other financing activities rose 99.62% year-over-year to -$89000.0; the TTM value through Dec 2025 reached -$116000.0, down 119.59%, while the annual FY2025 figure was -$249000.0, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was -$89000.0 at Haemonetics, down from -$27000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $23.1 million in Q2 2024 and troughed at -$23.4 million in Q4 2024.
  • A 5-year average of $936214.3 and a median of -$12500.0 in 2022 define the central range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 12666.67% in 2022 and fell as far as 5127.27% in 2022.
  • Year by year, Other financing activities stood at -$9000.0 in 2021, then crashed by 12677.78% to -$1.2 million in 2022, then increased by 29.22% to -$814000.0 in 2023, then tumbled by 2769.41% to -$23.4 million in 2024, then skyrocketed by 99.62% to -$89000.0 in 2025.
  • Business Quant data shows Other financing activities for HAE at -$89000.0 in Q4 2025, -$27000.0 in Q1 2025, and -$23.4 million in Q4 2024.